 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | BAC / Charsire Biotech
Enrollment change, Trial withdrawal: BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Jul 30, 2019
P2, N=0, Withdrawn, Sponsor: Charsire Biotechnology Corp.
N=125 --> 0 | Not yet recruiting --> Withdrawn
- | BAC / Charsire Biotech
Trial completion, Enrollment change, Trial completion date: A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Jul 29, 2019
P2, N=80, Completed, Sponsor: Charsire Biotechnology Corp.
N=125 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | N=60 --> 80 | Trial completion date: Nov 2019 --> Nov 2018
- | BAC / Charsire Biotech
Trial completion date, Trial primary completion date: BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Jul 18, 2018
P2, N=125, Not yet recruiting, Sponsor: Charsire Biotechnology Corp.
Recruiting --> Completed | N=60 --> 80 | Trial completion date: Nov 2019 --> Nov 2018 Trial completion date: Dec 2017 --> Dec 2021 | Trial primary completion date: Dec 2017 --> Jun 2021
- ||| BAC / Charsire Biotech
Trial initiation date: BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Jul 21, 2017
P2, N=125, Not yet recruiting, Sponsor: Charsire Biotechnology Corp.
Trial completion date: Dec 2017 --> Dec 2021 | Trial primary completion date: Dec 2017 --> Jun 2021 Initiation date: Mar 2017 --> Dec 2017
- |||| BAC / Charsire Biotech
Enrollment open: A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Apr 6, 2017
P2, N=60, Recruiting, Sponsor: Charsire Biotechnology Corp.
Initiation date: Mar 2017 --> Dec 2017 Not yet recruiting --> Recruiting
- ||| BAC / Charsire Biotech
Trial initiation date: BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Feb 15, 2017
P2, N=125, Not yet recruiting, Sponsor: Charsire Biotechnology Corp.
Not yet recruiting --> Recruiting Initiation date: Mar 2016 --> Mar 2017
- ||||| BAC / Charsire Biotech
New P2 trial: A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Sep 1, 2016
P2, N=60, Not yet recruiting, Sponsor: Charsire Biotechnology Corp.
- ||| BAC / Charsire Biotech
Trial initiation date: BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Jan 28, 2016
P2, N=125, Not yet recruiting, Sponsor: Charsire Biotechnology Corp.
Initiation date: Mar 2016 --> Mar 2017 Initiation date: Sep 2015 --> Mar 2016
- ||||| BAC / Charsire Biotech
New P2 trial: BAC in Patient With Alzheimer's Disease or Vascular Dementia (clinicaltrials.gov) - Jun 10, 2015
P2, N=125, Not yet recruiting, Sponsor: Charsire Biotechnology Corp.